Theranos Inc

PALO ALTO, CA · CIK 0001313697 · Medtech · Defunct

Automated blood testing platform for rapid diagnostic analysis from microvolume samples

theranos.tech →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$627M
2 Form D · May 2017
113 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$45,000,000
Private capital raisedForm D · SEC$582,200,318
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1951Intact Vascular—$80M
1952BioIntelliSense, Inc.—$140M
1953KitoTech Medical, Inc.—$16M
1954Theranos Inc—$627M
1955NOVAFLUX, INC.——
1956Artisight, Inc.——
1957ENDOMIMETICS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Ramesh BalwaniDirector · Executive Officer
  • Fabrizio BonanniDirector
  • William FoegeDirector
  • Elizabeth HolmesDirector · Executive Officer
  • Donald LucasDirector
  • Channing RobertsonDirector
  • Robert ShapiroDirector
  • T. Peter ThomasDirector
  • Daniel WarmenhovenDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.